These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14082244)

  • 1. FIBRINOGEN AS A PART OF PLATELET STRUCTURE.
    GOKCEN M; YUNIS E
    Nature; 1963 Nov; 200():590-1. PubMed ID: 14082244
    [No Abstract]   [Full Text] [Related]  

  • 2. [FIBRINOLYSIS INHIBITORS AND DETERMINATION OF PHYSIOLOGICAL AND PATHOLOGICAL ANTIPLASMIN ACTIVITY].
    MORIAU M; DE VRIES SI; DIK HJ
    Thromb Diath Haemorrh; 1964 Jan; 10():355-78. PubMed ID: 14113376
    [No Abstract]   [Full Text] [Related]  

  • 3. THE USE OF HUMAN BLOOD DERIVATIVES IN A POPULATION WHERE SUCH PRODUCTS ARE READILY AVAILABLE IN ADEQUATE QUANTITY WITHOUT COST.
    ANDERSON HD
    Bibl Haematol; 1964; 19():669-75. PubMed ID: 14267089
    [No Abstract]   [Full Text] [Related]  

  • 4. INFLUENCE OF FIBRINOGEN DEGRADATION PRODUCTS (FDP) ON PLATELET AGGREGATION, ADHESIVENESS AND VISCOUS METAMORPHOSIS.
    KOWALSKI E; KOPEC M; WEGRZYNOWICZ Z
    Thromb Diath Haemorrh; 1964 Jan; 10():406-23. PubMed ID: 14113380
    [No Abstract]   [Full Text] [Related]  

  • 5. FATE OF STREPTOCOCCAL M PROTEIN AFTER EXPOSURE TO PLASMIN AND HUMAN LEUKOCYTES.
    KANTOR FS
    Yale J Biol Med; 1964 Feb; 36(4):259-67. PubMed ID: 14119861
    [No Abstract]   [Full Text] [Related]  

  • 6. [PRELIMINARY STUDIES ON HUMORAL FACTORS IN RHEUMATOID ARTHRITIS].
    BREWER EJ; FAHLBERG WJ
    Rev Med Chil; 1964 Mar; 92():191-3. PubMed ID: 14169683
    [No Abstract]   [Full Text] [Related]  

  • 7. [RESEARCH ON THE ENZYMATIC ACTIVITIES OF PLASMIN AND STREPTOKINASE].
    VAUXSAINT CYR
    Biol Med (Paris); 1963; 52():611-30. PubMed ID: 14095161
    [No Abstract]   [Full Text] [Related]  

  • 8. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS.
    TYLER HM; LACK CH
    Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258
    [No Abstract]   [Full Text] [Related]  

  • 9. THE CASEINOLYTIC METHOD FOR DETERMINATION OF PLASMINOGEN-PLASMIN IN HUMAN PLASMA AND SERUM.
    JACOBSEN CD
    Scand J Clin Lab Invest; 1964; 16():372-82. PubMed ID: 14202017
    [No Abstract]   [Full Text] [Related]  

  • 10. ACTION OF THE NEW ANTI-FIBRINOLYTIC SUBSTANCE ON THE STREPTOKINASE-ACTIVATED PROTEASES (PLASMINS).
    MIHARA H
    Kobe J Med Sci; 1963 Dec; 18():169-77. PubMed ID: 14160537
    [No Abstract]   [Full Text] [Related]  

  • 11. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON BLOOD COAGULATION IN DOGS.
    LEWIS JH; SHIRAKAWA M
    Am J Physiol; 1964 Nov; 207():1049-52. PubMed ID: 14237448
    [No Abstract]   [Full Text] [Related]  

  • 12. A streptokinase confactor in human platelets.
    LEWIS JH; WILSON JH; MERCHANT WR
    Proc Soc Exp Biol Med; 1962 Feb; 109():248-50. PubMed ID: 14464878
    [No Abstract]   [Full Text] [Related]  

  • 13. STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS.
    KOWALSKI E; BUDZYNSKI AZ; KOPEC M; LATALLO ZS; LIPINSKI B; WEGRZYNOWICZ Z
    Thromb Diath Haemorrh; 1964 Oct; 12():69-86. PubMed ID: 14224647
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of trypsin on the fibrinolytic system of normal serum treated with plasmin or streptokinase].
    GIACOMAZZI G
    Haematologica; 1962; 47():875-906. PubMed ID: 13947574
    [No Abstract]   [Full Text] [Related]  

  • 15. MECHANISM OF HUMAN PLASMINOGEN ACTIVATION BY STREPTOKINASE AND HUMAN PLASMIN.
    BLATT WF; GRAY JL; JENSEN H
    Thromb Diath Haemorrh; 1964 Apr; 11():85-93. PubMed ID: 14167118
    [No Abstract]   [Full Text] [Related]  

  • 16. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS.
    TICE DA; WORTH MH; CLAUSS RH; REED GH
    Surg Gynecol Obstet; 1964 Jul; 119():71-4. PubMed ID: 14179354
    [No Abstract]   [Full Text] [Related]  

  • 17. THROMBOLYTIC THERAPY.
    FLUTE PT
    J Clin Pathol; 1964 May; 17(3):333-5. PubMed ID: 14159475
    [No Abstract]   [Full Text] [Related]  

  • 18. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS.
    BACK N; HIRAMOTO R; AMBRUS JL
    Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764
    [No Abstract]   [Full Text] [Related]  

  • 19. EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD.
    BRAKMAN P; ASTRUP T
    Lancet; 1964 Jul; 2(7349):10-2. PubMed ID: 14149193
    [No Abstract]   [Full Text] [Related]  

  • 20. PLASMA AMIDASE AND AMYLASE ACTIVITY IN PATIENTS UNDERGOING OPERATION.
    GULLICK HD
    Surgery; 1965 Feb; 57():230-40. PubMed ID: 14263794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.